Total Glove Company Sdn Bhd (Total Glove) concluded with the Dutch based research and development company BUDEV B.V. an exclusive license agreement to commercialize latex examination and surgical gloves treated with the breakthrough MPXX™ technology
TOTAL GLOVE BUSINESS APPROACH
By having the exclusive license on the MPXX™ technology Total Glove is able to treat also your gloves and reduce the major allergens clinically proven to cause latex allergy to unquantifiable levels under the FITkit® test method. The gloves treated will maintain their mechanical properties and will meet all international standards.
Besides being able to prevent new latex allergy type I cases the application of the MPXX™ technology will reduce the chemical residues to undetectable levels, thus reducing the risk on type IV allergies.
Total Glove is pleased to discuss with you the possibilities of a fruitful cooperation.